🔎 Trials Near Me

Home › Leucemia mieloide acuta › Georgia › Atlanta

Studi clinici su Leucemia mieloide acuta a Atlanta, GA

30 studi su Leucemia mieloide acuta cercano partecipanti presso sedi a Atlanta e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.

Testo ufficiale dello studio (inglese)

Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

In reclutamentoFase 2/3
  • Winship Cancer Institute of Emory University /ID# 279006, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07581002

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

In reclutamentoStudio osservazionaleVolontari sani benvenuti
  • Atlanta VA Medical Center, Decatur · a 6 mi di distanza
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

In reclutamentoFase 1
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06484062

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

In reclutamentoStudio osservazionale
  • Children's Healthcare of Atlanta - Arthur M. Blank Hospital, Atlanta
Età da 0 a 38 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06131801

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

In reclutamentoFase 1
  • Emory University, Atlanta
Età da 12 a 78 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT03802695

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

In reclutamentoFase 1
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Fino a 21 anni · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07012044

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

In reclutamentoFase 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
6 Months – 21 Years · Tutti i sessi · Aggiornato il 17 set 2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

In reclutamentoFase 1/2
  • Emory Winship Cancer Institute, Atlanta
30 Days · Tutti i sessi · Aggiornato il 16 set 2026 · NCT04065399

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

In reclutamentoFase 2
  • Winship Cancer Institute - Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 set 2026 · NCT04996875

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

In reclutamentoFase 3
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Età da 1 a 25 · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07022678

Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML

In reclutamentoFase 3
  • US-Atlanta GA-EMORY, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06652438

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • US-Atlanta GA-EMORY, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 set 2026 · NCT07223814

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

In reclutamentoFase 1/2
  • Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Fino a 22 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

In reclutamentoFase 3
  • Children's Healthcare of Atlanta, Atlanta
29 Days – 21 Years · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

In reclutamentoFase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT06001788

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

In reclutamentoFase 1
  • Children's Healthcare of Atlanta, Atlanta
Età da 1 a 30 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06177067

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

In reclutamentoFase 1Volontari sani benvenuti
  • Northside Hospital, Atlanta
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 lug 2026 · NCT07020533

Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT

In reclutamentoFase 3
  • Emory University - Winship Cancer Institute (WCI), Atlanta
Età da 18 a 75 · Tutti i sessi · Aggiornato il 17 lug 2026 · NCT05429632

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

In reclutamentoStudio osservazionale
  • Children's Healthcare of Atlanta, Atlanta
  • Northside Hospital, Atlanta
Tutte le età · Tutti i sessi · Aggiornato il 6 lug 2026 · NCT01351545

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

In reclutamentoFase 1/2
  • Emory Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 giu 2026 · NCT04068597

Ivosidenib as Post-HSCT Maintenance for AML

In reclutamentoFase 2
  • Emory University Hospital, Atlanta
Età da 18 a 75 · Tutti i sessi · Aggiornato il 18 giu 2026 · NCT06707493

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

In reclutamentoFase 1
  • Winship Cancer Institute / Emory University, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 15 giu 2026 · NCT05768932

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

In reclutamentoFase 2/3
  • University of Emory - Winship Cancer Institute, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 apr 2026 · NCT04256317

Pilot Imaging Study of Leukemia

In reclutamentoFase 1
  • Emory University, Atlanta
Età da 4 a 80 · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT03633955

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

In reclutamentoFase 1
  • Emory Healthcare - The Emory Clinic, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 mar 2026 · NCT05735184

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

In reclutamentoFase 2Volontari sani benvenuti
  • Northside Hospital, Atlanta
Età da 18 a 75 · Tutti i sessi · Aggiornato il 10 mar 2026 · NCT06059391

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

In reclutamentoFase 1
  • Emory University Hospital, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 gen 2026 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

In reclutamentoFase 1
  • Emory University - WINSHIP Cancer Center, Atlanta
  • Emory University, Children's Healthcare of Atlanta, Atlanta
Età 12 e oltre · Tutti i sessi · Aggiornato il 8 gen 2026 · NCT04872478

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

In reclutamentoFase 1
  • Blood and Marrow Transplant Group of Georgia, Atlanta
Età 18 e oltre · Tutti i sessi · Aggiornato il 31 ott 2025 · NCT06549790

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

In reclutamentoVolontari sani benvenuti
  • Emory University, Atlanta
Età da 18 a 120 · Tutti i sessi · Aggiornato il 25 lug 2025 · NCT05237258

Studi su Leucemia mieloide acuta in altre città

Altri studi a Atlanta

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.